DERMACORT HYDROCORTISONE CREAM

Active substance: HYDROCORTISONE

View full screen / Print PDF » Download PDF ⇩

Transcript
....

ID
Cl)

~

u.

Format: 148 x 165 mm
Farbe: schwarz

PHARBIL Waltrop GmbH
Postfach 390 . 45725 Waltrop Tel. : 02309/9375-0 Fax:02309/9375-392

Materialnummer

817 16 15 I . 18 I0 I . 12 15

I

VersionsNummer

Korrektur

o 12

1

I

PACKAGE LEAFLET: INFORMATION FOR THE USER

Dermacort Hydrocortisone Cream
- Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet.You may need to read it again.
- If you have any further questions, please ask your doctor or pharmacist.
Do not pass this medicine on to others. It may harm them, even if their symptoms are the same as yours.
In this leaflet:
1. What Dermacort is and what it is used for
2. Before you use Dermacort
3. How to use Dermacort
4. Possible side effects
5. How to store Dermacort
6. Further information
1. WHAT DERMACORT IS AND WHAT IT IS USED FOR
The name of the medicine is Dermacort. The active ingredient is 0.1 % Hydrocortisone, in a lanolin-free
cream base that is quickly absorbed into the skin to treat the irritation that causes itching. Dermacort
reduces swelling and redness and allows healing .
Dermacort can be used for the treatment of skin irritations, dermatitis and rashes due to reactions to
plants, insect bites, jewellery, toiletries, deodorants, soaps and detergents. It may also be used for the
treatment of mild to moderate eczema.
2. BEFORE YOU USE DERMACORT
Do not use Dermacort:
• if you have had an allergy to any creams or ointments in the past
• on the eyes or face
• on the ano-genital region
• on broken or infected skin, including cold sores, acne and athlete's foot
• if you think you may be pregnant
• in children under 10 years of age without medical advice.
Important information about some of the ingredients of Dermacort
Dermacort contains propylene glycol which may cause skin irritation.
3. HOW TO USE DERMACORT
Dermacort is for 'EXTERNAL USE ONLY.'
_ . Adults and children over 10 years: Apply a thin layer to cover the affected area once or twice a day.
_ . You should find that:
- two fingertips of cream will treat both hands or one foot
- three fingertips of cream will treat one arm
• You should only apply the cream to the affected area.
• Rub in gently until the cream disappears.
• Wash your hands before and after application, unless
used for treating the hands.
8765.80.25102

I

I

-

~

Q)
(J)

co

LL

Format: 148 x 165 mm
Farbe: schwarz

PHARBIL Waltrop GmbH
Postfach 390 · 45725 Waltrop Tel.: 02309/9375-0 Fax:02309/9375-392

Materialnummer

VersionsNummer

817 16 15 I . 18 I0 I . 12 15 o 12

Korrektur

1

Do not use Dermacort for more than one week. If the condition does not improve after one week
consult your doctor.
4. POSSIBLE SIDE EFFECTS
You may find that your condition gets worse during treatment, you may be allergic to the cream or have
a skin infection. If this happens stop using the cream and contact your doctor or pharmacist as
soon as possible.

-

5. HOW TO STORE DERMACORT
Do not use Dermacort after the expiry date stamped on the tube and the pack. The expiry date refers to
the last day of the month .
Dermacort should be stored in a cool, dry place (below 25' C) .
Keep this medicine out of the sight and reach of children
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These measures will help protect the environment.
6. FURTHER INFORMATION
What Dermacort contains
The cream does not contain Lanolin.
Then active substance in Dermacort is 0.1% Hydrocortisone.
The other ingredients are propylene glycol, emulsifying ointment, citric acid and purified water.
Contents of the pack
Dermacort is available in packs of 15g.
Marketing Authorisation Holder
Marlborough Pharmaceuticals Ltd .
35A High Street, Marlborough, Wilts SN8 1LW, UK
Tel 01672 514187

o

PL 23138/0007

Manufacturer
PHARBIL Waltrop GmbH, Im Wirrigen 25, 0-45731 , Waltrop, Germany
Dermacort is a registered trademark.

For information in large print,
=tape, CD or Braille,
telephone 01672 514187
This leaflet was last approved in January 2014
8765.80.25102

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)